FABP 2 gene polymorphism and metabolic syndrome in elderly people of Croatian descent;Polimorfizam gena FABP 2 i metabolički sindrom u starijih osoba hrvatskog porijekla

Biochemia Medica

Volumn 22, Issue 2, 2012, Pages 217-224

  Turkovic, Lana Feher ^a   Pizent, Alica ^b   Dodig, Slavica ^c   Pavlovic, Mladen ^b   Pasalic, Daria ^d  

^a University of Applied Health Studies Zagreb   (Croatia)

^b INSTITUTE FOR MEDICAL RESEARCH AND OCCUPATIONAL HEALTH   (Croatia)

^c SREBRNJAK CHILDREN S HOSPITAL   (Croatia)

^d UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

FABP2; Fatty acid binding proteins (FABPs); Genetic polymorphism; Metabolic syndrome

Indexed keywords

ALANINE; C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; THREONINE; FABP2 PROTEIN, HUMAN; FATTY ACID BINDING PROTEIN; LIPID; TRIACYLGLYCEROL;

AGED; ARTICLE; CROATIA; DIET RESTRICTION; FATTY ACID BINDING PROTEIN 2 GENE; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; ANTHROPOMETRY; BIOSYNTHESIS; BLOOD; CROSS-SECTIONAL STUDY; DYSLIPIDEMIA; GENETICS; METABOLISM; METHODOLOGY;

AGED; AGED, 80 AND OVER; ANTHROPOMETRY; C-REACTIVE PROTEIN; CHOLESTEROL, HDL; CROSS-SECTIONAL STUDIES; DYSLIPIDEMIAS; FATTY ACID-BINDING PROTEINS; FEMALE; GENOTYPE; HUMANS; LIPIDS; MALE; METABOLIC SYNDROME X; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; TRIGLYCERIDES;

EID: 84865386212     PISSN: 13300962     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Tanner RM, Brown TM, Muntner P. Epidemiology of Obesity, the Metabolic Syndrome, and Chronic Kidney Disease. Curr Hypertens Rep 2012;14:152-9.
2. Grundy SM. Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol 2008;28:629-36.
3. Thiruvagounder M, Khan S, Sultan Sheriff D. The prevalence of metabolic syndrome in a local population in India. Biochem Med 2010;20:249-52.
4. Pašalić D, Marinković N, Feher-Turković L. Uric acid as one of the important factors in multifactorial disorders-facts and controversies. Biochem Med 2012;22:63-75.
5. Blaton VH, Korita I, Bulo A. How is metabolic syndrome related to dyslipidemia? Biochem Med 2008;18:14-24.
6. Farhangi MA, Ostadrahimi A, Mahboob S. Serum calcium, magnesium, phosphorous and lipid profile in healthy Iranian premenopausal women. Biochem Med 2011;21:312-20.
7. Povel CM, Boer JM, Reiling E, Feskens EJ. Genetic variants and the metabolic syndrome: a systematic review. Obes Rev 2011;12:952-67.
8. Garaulet M, Madrid JA. Chronobiology, genetics and metabolic syndrome. Curr Opin Lipidol 2009;20:127-34.
9. Dujic T, Bego T, Mlinar B, Semiz S, Malenica M, Prnjavorac B, et al. Association between 11β-hydroxysteroid dehydrogenase type 1 gene polymorphisms and metabolic syndrome. Biochem Med 2012;22:76-85.
10. Sacchettini JC, Gordon JI, Banaszak LJ. The Structure of Crystalline Escherichia coli-derived Rat Intestinal Fatty Acid-binding protein at 2.5-Å Resolution. J Biol Chem 1988;263:5815-9.
11. Lin HH, Han LY, Zhang HL, Zheng CJ, Xie B, Chen YZ. Prediction of the functional class of lipid binding proteins from sequence-derived properties irrespective of sequence similarity. J Lipid Res 2006;47:824-31.
12. Hanhoff T, Lücke C, Spener F. Insights into binding of fatty acids by fatty acid binding proteins. Mol Cell Biochem 2002;239:45-54.
13. Chmurzynska A. The multigene family of fatty acid-binding proteins (FABPs): Function, structure and polymorphism. J Appl Genet 2006;47:39-48.
14. Weiss EP, Brown MD, Shuldiner AR, Hagberg JM. Fatty acid binding protein-2 gene variants and insulin resistance: gene and gene-environment interaction effects Physiol Genomics 2002;10:145-57.
15. Sweetser DA, Birkenmeier EH, Klisak IJ, Zollman S, Sparkes RS, Mohandas T, et al. The Human and Rodent Intestinal Fatty Acid Binding Protein Genes. J Biol Chem 1987;262:16060-71.
16. Zhang F, Lücke C, Baier LJ, Sacchettini JC, Hamilton JA. Solution structure of human intestinal fatty acid binding protein with a naturally-occurring single amino acid substitution (A54T) that is associated with altered lipid metabolism. Biochemistry 2003;42:7339-47.
17. Chamberlain AM, Schreiner PJ, Fornage M, Loria CM, Siscovick D, Boerwinkle E. Ala54Thr polymorphism of the fatty acid binding protein 2 gene and saturated fat intake in relation to lipid levels and insulin resistance: the Coronary Artery Risk Development in Young Adults (CARDIA) study. Metabolism 2009;58:1222-8.
18. Zhao T, Nzekebaloudou M, Iv J. Ala54Thr polymorphism of fatty acid-binding protein 2 gene and fasting blood lipids: a meta-analysis. Atherosclerosis 2010;210:461-7.
19. de Luis DA, Gonzalez Sagrado M, Aller R, Izaola O, Conde R. Metabolic syndrome and ALA54THR polymorphism of fatty acid-binding protein 2 in obese patients. Metabolism 2011;60:664-8.
20. Zhao T, Zhao J, Lv J, Nzekebaloudou M. Meta-analysis on the effect of the Ala54Thr polymorphism of the fatty acid-binding protein 2 gene on body mass index. Nutr Metab Cardiovasc Dis 2011;21:823-9.
21. Zhao T, Zhao J, Yang W. Association of the fatty acid-binding protein 2 gene Ala54Thr polymorphism with insulin resistance and blood glucose: a meta-analysis in 13451 subjects. Diabetes Metab Res Rev 2010;26:357-64.
22. Pašalić D, Dodig S, Corović N, Pizent A, Jurasović J, Pavlović M. High prevalence of metabolic syndrome in an elderly Croatian population-a multicentre study. Public Health Nutr 2011;14:1650-7.
23. Pizent A, Pavlovic M, Jurasovic J, Dodig S, Pasalic D, Mujagic R. Antioxidants, trace elements and metabolic syndrome in elderly subjects. J Nutr Health Aging 2010;14:866-71.
24. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640-5.
25. Weiner JS, Lourie JA. Practical Human Biology. Academic Press., London, England (1981).
26. Mean arterial pressure (MAP) Calculator. Available at: http://www.globalrph.com/map.htm. Last updated: 09/17/2011 23:40:30. Accessed February 29th, 2012.
27. Friedewald WT. Levy RI, Fredricson DS. Estimation of the concentrations of low density lipoprotein-cholesterol in plasma, without use the preparative centrifuge. Clin Chem 1972;18:499-502.
28. Baier LJ, Sacchettini JC, Knowler WC, Eads J, Paolisso G, Tataranni PA, et al. An amino acid substitution in the human intestinal fatty acid binding protein is associated with increased fatty acid binding, increased fat oxidation, and insulin resistance. J Clin Invest 1995;95:1281-7.
29. Colley SP, Georgopoulos A, Young LR, Kurzer MS, Redmon JB, Raatz SK. A high-fat diet and the threonine-encoding allele (Thr54) polymorphism of fatty acid-binding protein 2 reduce plasma triglyceride-rich lipoproteins. Nutr Res 2011;31:503-8.
30. Gastaldi M, Dizière S, Defoort C, Portugal H, Lairon D, Darmon M, Planells R. Sex-specific association of fatty acid binding protein 2 and microsomal triacylglycerol transfer protein variants with response to dietary lipid changes in the 3-mo Medi-RIVAGE primary intervention study. Am J Clin Nutr 2007;86:1633-41.
31. Oguri M, Kato K, Yokoi K, Itoh T, Yoshida T, Watanabe S, et al. Association of genetic variants with myocardial infarction in Japanese individuals with metabolic syndrome. Atherosclerosis 2009;206:486-93.
32. Storch J, Thumser AE. Tissue-specific functions in the fatty acid-binding protein family. J Biol Chem 2010;285:32679-83.
33. Pratley RE, Baier L, Pan DA, Salbe AD, Storlien L, Ravussin E, Bogardus C. nEffects of an Ala54Thr polymorphism in the intestinal fatty acid-binding protein on responses to dietary fat in humans. J Lipid Res 2000;41:2002-8.